Greehey CCRI Seminar Series: James Amatruda, MD, PhD, (Children’s Hospital Los Angeles)

Event Date & Time

October 25, 2024-October 25, 2024 at 12:00P - 1:00P

Location

Greehey CCRI Auditorium (2.160)

Save to Calendar

Add to Calendar

About the Speaker(s)

Interim Chief and Interim Director, Cancer and Blood Disease Institute
Head, Basic and Translational Research, Cancer and Blood Disease Institute
Dr. Kenneth O. Williams Chair in Cancer Research
Children's Hospital Los Angeles
Professor of Pediatrics and Medicine, Keck School of Medicine of USC
James F. Amatruda, MD, PhD is the Interim Chief of the Division of Pediatric Hematology-Oncology, Interim Director of the Cancer and Blood Disease Institute (CBDI), Head of Basic and Translational Research in the CBDI, and the Dr. Kenneth O. Williams Chair in Cancer Research at Children’s Hospital Los Angeles (CHLA). He is also a tenured Professor of Pediatrics and Medicine at the USC Keck School of Medicine and the Interim Associate Director for Pediatric Oncology at the USC Norris Comprehensive Cancer Center. He received his Bachelor’s degree in Biochemical Sciences from Harvard University and his MD and PhD from Washington University School of Medicine. He did internship and residency training in Internal Medicine at the Brigham and Women’s Hospital in Boston, MA, followed by fellowship training in Medical Oncology at Dana-Farber/Partners Cancer Care in Boston, MA. He was a Postdoctoral Fellow in the laboratory of Dr. Leonard Zon at Boston Children’s Hospital, Harvard Medical School. From 2005-2019, Dr. Amatruda was on the UT Southwestern Medical Center faculty in Dallas, TX.

Dr. Amatruda is a physician-scientist with a primary research and clinical focus on solid tumors of childhood, including sarcomas, germ cell tumors, and Wilms tumors. His lab has developed zebrafish models of genetic subtypes of pediatric solid tumors to better define their biology and to use that knowledge to identify and validate novel approaches for improved therapies. He has had long-standing leadership positions in the Children’s Oncology Group, serving as Chair for the Germ Cell Tumor Biology Committee and the Rare Tumors Biology Committee. He also serves as a member of the COG Solid Malignancies Integrated Translational Science Center Steering Committee and on the Scientific Advisory Boards of the William Guy Forbeck Foundation, the Osteosarcoma Institute, the Pablove Foundation, Curing Kids Cancer and the 1 Million 4 Anna Foundation.

More about Dr. Amatruda's research: chla.org/profile/james-amatruda-md-phd

Hosted by: Alexander Pertsemlidis, PhD